Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 123531-52-2 | MDL No. : | MFCD11656766 |
Formula : | C10H10N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YHUJITROXZCZNW-UHFFFAOYSA-N |
M.W : | 190.20 | Pubchem ID : | 14358186 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.2 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 51.28 |
TPSA : | 43.6 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.82 cm/s |
Log Po/w (iLOGP) : | 2.34 |
Log Po/w (XLOGP3) : | 2.31 |
Log Po/w (WLOGP) : | 1.51 |
Log Po/w (MLOGP) : | 0.94 |
Log Po/w (SILICOS-IT) : | 1.09 |
Consensus Log Po/w : | 1.64 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.75 |
Solubility : | 0.336 mg/ml ; 0.00177 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.86 |
Solubility : | 0.26 mg/ml ; 0.00137 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.57 |
Solubility : | 0.513 mg/ml ; 0.0027 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.94 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 88047-55-6 ]
Methyl imidazo[1,2-a]pyridine-5-carboxylate
Similarity: 0.90
[ 1260797-60-1 ]
Ethyl 6-chloroimidazo[1,2-a]pyridine-3-carboxylate
Similarity: 0.90
[ 943112-78-5 ]
Methyl 2-methylimidazo[1,2-a]pyridine-3-carboxylate
Similarity: 0.89
[ 1359655-87-0 ]
Ethyl 6-fluoroimidazo[1,2-a]pyridine-3-carboxylate
Similarity: 0.89
[ 372198-69-1 ]
Ethyl 6-bromoimidazo[1,2-a]pyridine-3-carboxylate
Similarity: 0.89
[ 6200-60-8 ]
Imidazo[1,2-a]pyridine-3-carboxylic acid
Similarity: 0.91
[ 88047-55-6 ]
Methyl imidazo[1,2-a]pyridine-5-carboxylate
Similarity: 0.90
[ 1260797-60-1 ]
Ethyl 6-chloroimidazo[1,2-a]pyridine-3-carboxylate
Similarity: 0.90
[ 943112-78-5 ]
Methyl 2-methylimidazo[1,2-a]pyridine-3-carboxylate
Similarity: 0.89
[ 372198-69-1 ]
Ethyl 6-bromoimidazo[1,2-a]pyridine-3-carboxylate
Similarity: 0.89